about
Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiencyAlendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseasesOSU53 Rescues Human OB-6 Osteoblastic Cells from Dexamethasone through Activating AMPK SignalingManagement of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.Minireview: nuclear receptor regulation of osteoclast and bone remodeling.Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway.Clinical role of bisphosphonate therapy.Tanshinone IIA blocks dexamethasone-induced apoptosis in osteoblasts through inhibiting Nox4-derived ROS production.Understanding leptin-dependent regulation of skeletal homeostasisCurcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesOverexpression of integrin a2 promotes osteogenic differentiation of hBMSCs from senile osteoporosis through the ERK pathwayMechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk.Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trialChronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case reportmiR-135b expression downregulates Ppm1e to activate AMPK signaling and protect osteoblastic cells from dexamethasone.Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone.microRNA-25 targets PKCζ and protects osteoblastic cells from dexamethasone via activating AMPK signalingOsteoporosis and fractures in systemic lupus erythematosus.Management of glucocorticoid-induced osteoporosis.Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.Biomarkers of cartilage and surrounding joint tissue.Management of osteoporosis in rheumatoid arthritis patients.The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.EGFR-AKT-mTOR activation mediates epiregulin-induced pleiotropic functions in cultured osteoblasts.P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts.Current evidence on vitamin D deficiency and kidney transplant: What's new?Osteoinductive effects of preoperative dexamethasone in human dental pulp stem cells primary cultureSulforaphane reverses glucocorticoid-induced apoptosis in osteoblastic cells through regulation of the Nrf2 pathway.Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone.MicroRNA-200a activates Nrf2 signaling to protect osteoblasts from dexamethasone.Polygonum multiflorm alleviates glucocorticoid‑induced osteoporosis and Wnt signaling pathway.P21(Waf1/Cip1) depletion promotes dexamethasone-induced apoptosis in osteoblastic MC3T3-E1 cells by inhibiting the Nrf2/HO-1 pathway.microRNA-19a protects osteoblasts from dexamethasone via targeting TSC1.Glucocorticoids, Inflammation and Bone.Immune Suppressive and Bone Inhibitory Effects of Prednisolone in Growing and Regenerating Zebrafish Tissues.Fludarabine inhibits STAT1-mediated up-regulation of caspase-3 expression in dexamethasone-induced osteoblasts apoptosis and slows the progression of steroid-induced avascular necrosis of the femoral head in rats.The CRH-Transgenic Cushingoid Mouse Is a Model of Glucocorticoid-Induced Osteoporosis
P2860
Q26821908-8400CFEE-605B-4D28-A9A1-8B7D1CDB6A7DQ27314920-5D019BFD-E3E1-4612-870E-8ADBBE114546Q28554140-E6C8FAA4-B7F7-4C44-834D-59658AB9C035Q30946308-8BAA2A76-3907-4342-9241-260451E58DEFQ35054970-78A1A459-5415-4147-92B9-EA4FFC7FDF2AQ35725177-3C6608F0-5392-4E19-9535-9F8C4261169BQ36311593-900ABC68-3074-4CF8-A9C5-D8B4C35035ECQ36375631-E449AC18-75B9-410E-909F-F1AC91A614A4Q36439661-5AEEE989-EFAA-4ECE-802C-D5CACE46B82DQ36473722-2EDC5E6F-04C0-4CA3-94FD-BF955CD3B454Q36602853-2C875F94-C082-4076-A668-644F31A2859EQ36800314-26D713B9-B374-4062-8408-7FBCF3EC9CCCQ36917821-5310C454-1D2E-47B2-AE24-5517CFCF45E9Q37001737-CC33E971-8DE4-4B86-BAC6-13FF14FFEC41Q37567212-48579F1D-3C51-4CE4-AEE9-641A9485F4C3Q37688586-8B16E9A0-FFE6-4E47-8F82-8E68566BD5F3Q37709337-951FD264-5993-456B-96DB-8A0603B06E9EQ37709453-524B1AD9-9F7E-49F5-9B58-F686C9303E42Q37972874-4FFDE3E5-4FD6-492D-9AAC-4AD7DA27B1F1Q38033444-61A78339-5762-4D2A-A5BC-35F3F62BADA9Q38073889-A4445925-1CF0-4287-872B-B5B7FC4D3794Q38239828-FB6124CD-8D4D-4319-B910-E4B032374CA9Q38334318-B4904C37-0CBD-4545-A6BC-6A56D057125DQ38436495-1640EFED-F09D-47DA-8CFF-A08159588785Q38676353-3A90AE39-54F9-4CAB-9BA2-B188FAC90B61Q38956405-E83A5DB9-E72D-49BB-99C1-15825753568CQ39016683-CF9019A7-6C00-4E03-8194-12046A49DB49Q39172404-8C0385D5-085A-4B09-96AE-23DE05AB63BBQ41609250-2779A488-5038-49DB-80EC-69CECDA2AC72Q41785572-4DCD8B12-9936-4483-97C3-48A177C7A326Q46909890-1F91D142-E7B0-4F07-94FF-9C0DABF1B467Q47167976-F9008A15-2E15-409E-A246-336451C656BBQ47426896-077088B4-24CE-4247-B53A-5A2762F27D7EQ47757872-A8559AD1-7FF9-4CEE-A014-CD1AD8A23EDEQ50121276-0B1B6871-8194-434E-B5C5-227B73A45ADFQ50128187-55ECB728-F395-4983-ABF7-6621616BAD16Q51805648-7F0BA2C9-8772-4035-9B2A-75D2CCA633B9Q52860832-9544F3CF-B783-4FE8-B763-28E463FBED4BQ57153114-9F371E4D-817E-45F3-B3EC-BD3902512F6E
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Advances in glucocorticoid-induced osteoporosis
@ast
Advances in glucocorticoid-induced osteoporosis
@en
Advances in glucocorticoid-induced osteoporosis
@nl
type
label
Advances in glucocorticoid-induced osteoporosis
@ast
Advances in glucocorticoid-induced osteoporosis
@en
Advances in glucocorticoid-induced osteoporosis
@nl
prefLabel
Advances in glucocorticoid-induced osteoporosis
@ast
Advances in glucocorticoid-induced osteoporosis
@en
Advances in glucocorticoid-induced osteoporosis
@nl
P2860
P1476
Advances in glucocorticoid-induced osteoporosis
@en
P2093
Debby den Uyl
Willem F Lems
P2860
P2888
P304
P356
10.1007/S11926-011-0173-Y
P577
2011-06-01T00:00:00Z
P5875
P6179
1046426055